US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 5.6000
  • -0.1000-1.75%
Trading Oct 15 11:19 ET
145.40MMarket Cap-1104P/E (TTM)

Inovio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
12.70%-28.21M
21.56%-28.76M
42.48%-124.37M
27.69%-26.28M
56.85%-29.11M
36.05%-32.31M
40.75%-36.66M
-0.23%-216.22M
4.09%-36.34M
-45.12%-67.47M
Net income from continuing operations
9.28%-32.24M
25.04%-30.47M
51.71%-135.12M
54.09%-25M
10.20%-33.93M
67.25%-35.53M
48.59%-40.65M
7.85%-279.82M
49.07%-54.46M
37.20%-37.78M
Operating gains losses
-71.87%357.61K
-61.87%817.19K
-51.68%4.35M
-70.55%1.12M
-114.73%-184.1K
35.76%1.27M
-28.89%2.14M
806.47%9M
3,586.77%3.8M
2,078.32%1.25M
Depreciation and amortization
-27.53%828.63K
-34.06%759.73K
-36.25%3.5M
-87.01%175.23K
-24.16%1.03M
-18.91%1.14M
-16.25%1.15M
16.18%5.5M
-2.23%1.35M
17.87%1.36M
Deferred tax
----
----
---32.05K
----
----
----
----
--0
----
----
Other non cash items
--0
-61.66%-355.65K
-16.67%155.81K
-9.94%282.33K
0.00%-220K
0.00%313.49K
0.00%-220K
-78.22%186.98K
-34.73%313.49K
-285.19%-220K
Change In working capital
179.17%1.78M
-157.61%-851.25K
-151.73%-10.26M
-116.35%-2.11M
79.85%-7.38M
-105.19%-2.24M
329.31%1.48M
-60.61%19.83M
-78.14%12.91M
-791.61%-36.63M
-Change in receivables
1,058.35%777.42K
-102.18%-145.85K
351.82%9.33M
84.25%-261.03K
130.24%2.97M
97.91%-81.12K
1,138.45%6.7M
-133.60%-3.71M
-82.76%-1.66M
-80.81%1.29M
-Change in prepaid assets
-199.01%-1.85M
-95.18%1.9M
831.20%39.02M
-101.92%-264.56K
-22.57%-1.91M
107.57%1.87M
455.75%39.32M
15.88%-5.34M
-70.13%13.81M
-257.08%-1.56M
-Change in payables and accrued expense
215.27%3.28M
94.50%-2.5M
-264.92%-54.22M
-16.06%2.01M
71.36%-7.85M
-104.35%-2.84M
-507.22%-45.54M
23.98%32.87M
-84.65%2.39M
-6,180.78%-27.4M
-Change in other current assets
234.98%19.4K
--0
-89.39%78.73K
--0
-9.66%61.58K
-102.85%-14.37K
-79.26%31.53K
-96.98%741.75K
-94.55%17.94K
-10.06%68.16K
-Change in other current liabilities
--0
-105.31%-87.49K
-19.71%-2.45M
-281.76%-3.72M
-88.14%79.46K
81.16%-462.38K
132.57%1.65M
32.05%-2.05M
34.44%-974.1K
174.39%669.9K
-Change in other working capital
37.31%-446.59K
98.30%-11.79K
24.87%-2.02M
118.73%126.2K
92.36%-741.11K
-108.57%-712.38K
-9.31%-693.69K
-13.54%-2.69M
-1.14%-673.69K
-1,463.04%-9.7M
Cash from discontinued investing activities
Operating cash flow
12.70%-28.21M
21.56%-28.76M
42.48%-124.37M
27.69%-26.28M
56.85%-29.11M
36.05%-32.31M
40.75%-36.66M
-0.23%-216.22M
4.09%-36.34M
-45.12%-67.47M
Investing cash flow
Cash flow from continuing investing activities
-81.51%9.97M
138.86%45.38M
-20.29%87.36M
-63.07%19.94M
-112.33%-5.49M
623.16%53.91M
-10.93%19M
162.50%109.59M
931.55%54M
-20.38%44.56M
Net PPE purchase and sale
-1,791.09%-452.25K
-100.62%-35.58K
708.61%5.9M
189.80%148.26K
--0
96.67%-23.92K
--5.77M
21.27%-969.15K
74.35%-165.11K
48.50%-86.83K
Net business purchase and sale
----
----
--0
--0
----
----
----
---2M
--0
--0
Net investment purchase and sale
-80.68%10.42M
243.40%45.42M
-27.63%81.46M
-63.45%19.8M
-112.31%-5.49M
662.55%53.93M
-43.32%13.23M
164.64%112.56M
1,025.86%54.17M
-20.46%44.64M
Cash from discontinued investing activities
Investing cash flow
-81.51%9.97M
138.86%45.38M
-20.29%87.36M
-63.07%19.94M
-112.33%-5.49M
623.16%53.91M
-10.93%19M
162.50%109.59M
931.55%54M
-20.38%44.56M
Financing cash flow
Cash flow from continuing financing activities
1,045.85%33.03M
-2,575.77%-11.36M
-93.90%5M
-72.43%1.84M
-81.67%698.63K
-93.29%2.88M
-101.49%-424.7K
-61.30%81.84M
-85.99%6.67M
964.73%3.81M
Net issuance payments of debt
--0
---16.42M
----
----
----
--0
--0
----
----
----
Net common stock issuance
485.20%17.06M
--5.23M
-93.42%5.46M
-72.43%1.84M
-81.19%708.28K
-93.25%2.92M
--0
-60.39%82.96M
-85.91%6.67M
--3.77M
Proceeds from stock option exercised by employees
----
----
--0
--0
--0
----
----
-95.76%283.02K
--0
-63.39%93.5K
Net other financing activities
49,357.61%15.91M
58.97%-174.25K
66.61%-466.65K
--0
79.85%-9.65K
90.01%-32.29K
58.62%-424.7K
69.69%-1.4M
--0
93.12%-47.9K
Cash from discontinued financing activities
Financing cash flow
1,045.85%33.03M
-2,575.77%-11.36M
-93.90%5M
-72.43%1.84M
-81.67%698.63K
-93.29%2.88M
-101.49%-424.7K
-61.30%81.84M
-85.99%6.67M
964.73%3.81M
Net cash flow
Beginning cash position
-30.58%19.6M
-69.11%14.31M
-34.88%46.33M
-14.48%18.8M
28.25%52.71M
-52.15%28.24M
-34.88%46.33M
-71.63%71.14M
-67.64%21.99M
-30.25%41.1M
Current changes in cash
-39.57%14.79M
129.07%5.26M
-29.15%-32.01M
-118.47%-4.49M
-77.54%-33.91M
236.79%24.47M
-49.16%-18.09M
86.19%-24.79M
657.96%24.33M
-311.56%-19.1M
Effect of exchange rate changes
--0
1,789.42%32.4K
84.66%-3.92K
-96.09%483
87.27%-2.11K
97.46%-376
70.74%-1.92K
15.19%-25.56K
268.65%12.35K
-52.35%-16.56K
End cash Position
-34.75%34.39M
-30.58%19.6M
-69.11%14.31M
-69.11%14.31M
-14.48%18.8M
28.25%52.71M
-52.15%28.24M
-34.88%46.33M
-34.88%46.33M
-67.64%21.99M
Free cash flow
11.37%-28.66M
22.09%-28.8M
42.59%-124.69M
28.02%-26.28M
56.91%-29.11M
36.89%-32.34M
40.27%-36.96M
-0.11%-217.18M
5.27%-36.51M
-44.78%-67.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 12.70%-28.21M21.56%-28.76M42.48%-124.37M27.69%-26.28M56.85%-29.11M36.05%-32.31M40.75%-36.66M-0.23%-216.22M4.09%-36.34M-45.12%-67.47M
Net income from continuing operations 9.28%-32.24M25.04%-30.47M51.71%-135.12M54.09%-25M10.20%-33.93M67.25%-35.53M48.59%-40.65M7.85%-279.82M49.07%-54.46M37.20%-37.78M
Operating gains losses -71.87%357.61K-61.87%817.19K-51.68%4.35M-70.55%1.12M-114.73%-184.1K35.76%1.27M-28.89%2.14M806.47%9M3,586.77%3.8M2,078.32%1.25M
Depreciation and amortization -27.53%828.63K-34.06%759.73K-36.25%3.5M-87.01%175.23K-24.16%1.03M-18.91%1.14M-16.25%1.15M16.18%5.5M-2.23%1.35M17.87%1.36M
Deferred tax -----------32.05K------------------0--------
Other non cash items --0-61.66%-355.65K-16.67%155.81K-9.94%282.33K0.00%-220K0.00%313.49K0.00%-220K-78.22%186.98K-34.73%313.49K-285.19%-220K
Change In working capital 179.17%1.78M-157.61%-851.25K-151.73%-10.26M-116.35%-2.11M79.85%-7.38M-105.19%-2.24M329.31%1.48M-60.61%19.83M-78.14%12.91M-791.61%-36.63M
-Change in receivables 1,058.35%777.42K-102.18%-145.85K351.82%9.33M84.25%-261.03K130.24%2.97M97.91%-81.12K1,138.45%6.7M-133.60%-3.71M-82.76%-1.66M-80.81%1.29M
-Change in prepaid assets -199.01%-1.85M-95.18%1.9M831.20%39.02M-101.92%-264.56K-22.57%-1.91M107.57%1.87M455.75%39.32M15.88%-5.34M-70.13%13.81M-257.08%-1.56M
-Change in payables and accrued expense 215.27%3.28M94.50%-2.5M-264.92%-54.22M-16.06%2.01M71.36%-7.85M-104.35%-2.84M-507.22%-45.54M23.98%32.87M-84.65%2.39M-6,180.78%-27.4M
-Change in other current assets 234.98%19.4K--0-89.39%78.73K--0-9.66%61.58K-102.85%-14.37K-79.26%31.53K-96.98%741.75K-94.55%17.94K-10.06%68.16K
-Change in other current liabilities --0-105.31%-87.49K-19.71%-2.45M-281.76%-3.72M-88.14%79.46K81.16%-462.38K132.57%1.65M32.05%-2.05M34.44%-974.1K174.39%669.9K
-Change in other working capital 37.31%-446.59K98.30%-11.79K24.87%-2.02M118.73%126.2K92.36%-741.11K-108.57%-712.38K-9.31%-693.69K-13.54%-2.69M-1.14%-673.69K-1,463.04%-9.7M
Cash from discontinued investing activities
Operating cash flow 12.70%-28.21M21.56%-28.76M42.48%-124.37M27.69%-26.28M56.85%-29.11M36.05%-32.31M40.75%-36.66M-0.23%-216.22M4.09%-36.34M-45.12%-67.47M
Investing cash flow
Cash flow from continuing investing activities -81.51%9.97M138.86%45.38M-20.29%87.36M-63.07%19.94M-112.33%-5.49M623.16%53.91M-10.93%19M162.50%109.59M931.55%54M-20.38%44.56M
Net PPE purchase and sale -1,791.09%-452.25K-100.62%-35.58K708.61%5.9M189.80%148.26K--096.67%-23.92K--5.77M21.27%-969.15K74.35%-165.11K48.50%-86.83K
Net business purchase and sale ----------0--0---------------2M--0--0
Net investment purchase and sale -80.68%10.42M243.40%45.42M-27.63%81.46M-63.45%19.8M-112.31%-5.49M662.55%53.93M-43.32%13.23M164.64%112.56M1,025.86%54.17M-20.46%44.64M
Cash from discontinued investing activities
Investing cash flow -81.51%9.97M138.86%45.38M-20.29%87.36M-63.07%19.94M-112.33%-5.49M623.16%53.91M-10.93%19M162.50%109.59M931.55%54M-20.38%44.56M
Financing cash flow
Cash flow from continuing financing activities 1,045.85%33.03M-2,575.77%-11.36M-93.90%5M-72.43%1.84M-81.67%698.63K-93.29%2.88M-101.49%-424.7K-61.30%81.84M-85.99%6.67M964.73%3.81M
Net issuance payments of debt --0---16.42M--------------0--0------------
Net common stock issuance 485.20%17.06M--5.23M-93.42%5.46M-72.43%1.84M-81.19%708.28K-93.25%2.92M--0-60.39%82.96M-85.91%6.67M--3.77M
Proceeds from stock option exercised by employees ----------0--0--0---------95.76%283.02K--0-63.39%93.5K
Net other financing activities 49,357.61%15.91M58.97%-174.25K66.61%-466.65K--079.85%-9.65K90.01%-32.29K58.62%-424.7K69.69%-1.4M--093.12%-47.9K
Cash from discontinued financing activities
Financing cash flow 1,045.85%33.03M-2,575.77%-11.36M-93.90%5M-72.43%1.84M-81.67%698.63K-93.29%2.88M-101.49%-424.7K-61.30%81.84M-85.99%6.67M964.73%3.81M
Net cash flow
Beginning cash position -30.58%19.6M-69.11%14.31M-34.88%46.33M-14.48%18.8M28.25%52.71M-52.15%28.24M-34.88%46.33M-71.63%71.14M-67.64%21.99M-30.25%41.1M
Current changes in cash -39.57%14.79M129.07%5.26M-29.15%-32.01M-118.47%-4.49M-77.54%-33.91M236.79%24.47M-49.16%-18.09M86.19%-24.79M657.96%24.33M-311.56%-19.1M
Effect of exchange rate changes --01,789.42%32.4K84.66%-3.92K-96.09%48387.27%-2.11K97.46%-37670.74%-1.92K15.19%-25.56K268.65%12.35K-52.35%-16.56K
End cash Position -34.75%34.39M-30.58%19.6M-69.11%14.31M-69.11%14.31M-14.48%18.8M28.25%52.71M-52.15%28.24M-34.88%46.33M-34.88%46.33M-67.64%21.99M
Free cash flow 11.37%-28.66M22.09%-28.8M42.59%-124.69M28.02%-26.28M56.91%-29.11M36.89%-32.34M40.27%-36.96M-0.11%-217.18M5.27%-36.51M-44.78%-67.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Mpox (monkeypox)
Mpox (monkeypox)
Intraday+0.67%